Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 06/20/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study.

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab.

Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.

Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use.

Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma.

Non-infective cystitis secondary to benralizumab immunotherapy.

Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study).

Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.

Asthma and COVID-19: an update.

Paucigranulocytic asthma: Do sputum macrophages matter?

Distribution of inflammatory phenotypes among patients with asthma in Jilin Province, China: a cross-sectional study.

The Pathogenesis of Eosinophilic Asthma: A Positive Feedback Mechanism That Promotes Th2 Immune Response via Filaggrin Deficiency.

Showing 1-12 of 77

Last Updated : 06/20/2022